Review Article

Abnormal Sleep Duration as Predictor for Cardiovascular Diseases: A Systematic Review of Prospective Studies

Table 1

Baseline information of the 10 prospective cohort studies.

No.AuthorsYear of publicationCountryNumber of participantsBaseline yearFollow-up (years)Mean participants’ age (years)Male percentage (%)Sleep assessment toolOutcome assessed

1Song et al. [37]2015China95,9032006-2007Mean 3.9879.55QuestionnaireMyocardial infarction
2Girschik et al. [22]2016South Korea17152005-2008Mean 2.653.5436.68QuestionnaireHypertension
3Mallinson et al. [23]2016China32,1372006-2007Mean 3.9873.41QuestionnaireHypertension
4Yadav et al. [24]2016China8742011-2012Mean 256.1425.29InterviewHypertension
5Wang et al. [25]2016China19,3702008-20103 to 562.830.11QuestionnaireCoronary heart disease (nonfatal MI, stable angina, unstable angina, unspecified CHD, or CHD death)
6Song et al. [31]2016UK37232003968.13100QuestionnaireHeart failure
7Lao et al. [27]2017China87,6932006-2007Median 7.8950.5478.65QuestionnaireAtrial fibrillation
8Wang et al. [29]2017USA64411995-1998Median 11.446.5QuestionnaireCardiovascular disease (first event of nonfatal or fatal myocardial infarction, angina pectoris, revascularization procedure, or stroke)
9Yang et al. [26]2018Taiwan60,5861996-2014 (for total cohort)Mean 5.646.3InterviewCoronary heart disease
10Wannamethee et al. [28]2020China52,5992006, 2008, 2010Mean 6.776.1QuestionnaireCardiovascular events (atrial fibrillation, myocardial infarction, and stroke)